UNDERUTILIZATION OF BREAST-CONSERVING SURGERY AND RADIATION-THERAPY AMONG WOMEN WITH STAGE-I OR STAGE-II BREAST-CANCER
UNDERUTILIZATION OF BREAST-CONSERVING SURGERY AND RADIATION-THERAPY AMONG WOMEN WITH STAGE-I OR STAGE-II BREAST-CANCER
复制标题
DOI:
10.1001/jama.266.24.3433
复制
发表时间:
1991-12-25
影响因子:
120.7
通讯作者:
MOE, RE
中科院分区:
文献类型:
--
作者:
LAZOVICH, D;WHITE, E;MOE, RE
Objective. - To identify time trends and factors associated with breast-conserving surgery (BCS) and delivery of postoperative radiation therapy among women with stage I or II breast cancer.Design. - Survey.Setting. - Population-based cancer registry in the Seattle-Puget Sound (Wash) region.Participants. - The study included 8095 women diagnosed with stage I or II breast cancer (American Joint Committee on Cancer staging criteria) from 1983 through 1989.Main Outcome Measures. - Breast-conserving surgery with or without radiation therapy vs mastectomy, and, among women with BCS, a comparison of radiation therapy vs no therapy.Results. - In 1985 when results from a US randomized clinical trial of BCS were published, the frequency of BCS peaked (46.3% of stage I; 30.1 % of stage II) followed by a return to levels before 1985 for women with stage II breast cancer and a more moderate decline for stage I breast cancer. The likelihood of BCS decreased with increasing age (P < .001), with stage II disease, and with residence outside the region's major urban center, and it increased with education (P < .001) or median income (P < .001) by census tract. The proportion of women who received radiation therapy after BCS decreased with age (P < .001), was lower for women with stage II than stage I disease, and was lowest in counties without radiation therapy facilities.Conclusions. - Despite scientific evidence of the equivalent efficacy of BCS with radiation therapy and mastectomy, BCS is not performed on the majority of women with stage I or II breast cancer as recommended by the National Institutes of Health, and factors are associated with its use that differ from selection criteria outlined by the National Institutes of Health.